BioDelivery Sciences International, Inc.BDSI announced that supply of its opioid dependence drug, Bunavail, will be constrained in the near term due to a delay in releasing four new batches of the product to wholesalers. The delay is due to
BioDelivery's Bunavail Supply Hit by Specification Issues
